PharmaCyte Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMCB and other ETFs, options, and stocks.About PMCB
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes.
CEOJoshua Nathaniel Silverman
CEOJoshua Nathaniel Silverman
Employees2
Employees2
HeadquartersLas Vegas, Nevada
HeadquartersLas Vegas, Nevada
Founded1996
Founded1996
Employees2
Employees2
PMCB Key Statistics
Market cap5.69M
Market cap5.69M
Price-Earnings ratio-2.07
Price-Earnings ratio-2.07
Dividend yield—
Dividend yield—
Average volume14.38M
Average volume14.38M
High today$0.9597
High today$0.9597
Low today$0.822
Low today$0.822
Open price$0.9597
Open price$0.9597
Volume476.61K
Volume476.61K
52 Week high$1.90
52 Week high$1.90
52 Week low$0.63
52 Week low$0.63
Stock Snapshot
The current PharmaCyte Biotech(PMCB) stock price is $0.82, with a market capitalization of 5.69M. The stock trades at a price-to-earnings (P/E) ratio of -2.07.
During the trading session on 2025-12-17, PharmaCyte Biotech(PMCB) shares reached a daily high of $0.96 and a low of $0.82. At a current price of $0.82, the stock is 0.0% higher than the low and still -14.3% under the high.
Trading activity shows a volume of 476.61K, compared to an average daily volume of 14.38M.
The stock's 52-week range extends from a low of $0.63 to a high of $1.90.
The stock's 52-week range extends from a low of $0.63 to a high of $1.90.
People also own
Based on the portfolios of people who own PMCB. This list is generated using Robinhood data, and it’s not a recommendation.